Biocon

Biocon Announces Merger of Biologics Unit in $5.5 Billion Deal

The Indian biopharmaceutical giant Biocon has announced a major restructuring step by merging its well-known subsidiary, Biocon Biologics, into a fully owned entity valued at 5.5 billion dollars. The announcement has created strong interest in the healthcare and pharmaceutical market, since this move marks one of the most important corporate steps taken by Biocon in…

Kaynes Technology

Kaynes Technology Share Sees Sharp Rise in Futures Open Interest Among 6 F&O Stocks

What’s Driving Kaynes Technology’s Derivatives Activity Kaynes Technology has recently grabbed attention in the Indian markets with a sharp rise in futures open interest, placing it among six prominent F&O stocks seeing increased activity. Futures open interest (OI) refers to the total number of unclosed futures contracts for a stock and is a key indicator…